Leiomyomas Clinical Trials

A listing of Leiomyomas medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 662 clinical trials
Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant

with:

<ul>
  • Medical history
  • Physical exam
  • Blood and urine tests
  • Lung and heart tests
  • Eye exam
  • Bone marrow biopsy: A needle will be injected

    • 0 views
    • 12 Sep, 2021
    • 1 location
    A Study of TAK-105 in Healthy Adults

    It is hoped that in the future, TAK-105 will be used to help treat people with nausea and vomiting. The main aims of this study are as follows:

    <ul>
  • To check for side effects from TAK

    • 6 views
    • 10 Sep, 2021
    • 2 locations
    Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia

    rituximab administered concurrently with cladribine.

    Secondary
    <ul>
  • To compare cladribine plus rituximab vs cladribine alone in terms of 1) initial MRD-free survival and

    • 38 views
    • 16 Sep, 2021
    • 1 location
    Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy

    The purpose of this study is to assess the contraceptive efficacy of relugolix combination therapy.

    regular menstrual cycles
    • 0 views
    • 15 Sep, 2021
    • 38 locations
    Trial for Relapsed or Refractory AML Patients Combining Cytarabine and Mitoxantrone With Venetoclax (RELAX)

    This is an open-label Phase I dose-escalation study of oral venetoclax in combination with increasing cytarabine doses plus mitoxantrone to define the safety profile and MTD of cytarabine in subjects with a histologically or cytologically confirmed acute myeloid leukemia who are refractory or suffered a relapse. This study will be …

    acute promyelocytic leukemia
    cell transplantation
    induction chemotherapy
    refractory acute myeloid leukemia (aml)
    mitoxantrone
    • 0 views
    • 15 Sep, 2021
    • 2 locations
    Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)

    Background Pancreatic cancer is one of the most lethal types of cancer. ASCP is a highly aggressive type of pancreatic cancer. It is very rare. Researchers want to see if a drug called Minnelide can be used to treat ASCP. Objective To see if Minnelide is an effective treatment for …

    • 0 views
    • 19 Sep, 2021
    • 1 location
    EUS-Guided Choledochoduodenostomy Versus ERCP for Primary Biliary Decompression in Distal Malignant Biliary Obstruction

    Malignant biliary obstruction commonly caused by pancreatic adenocarcinoma, cholangiocarcinoma and other etiologies like gallbladder carcinoma, hepatocellular carcinoma, lymphoma, and metastasis to regional solid organs and lymph nodes. Pancreatobiliary cancers generally present with jaundice, weight loss, and anorexia with significant impact on quality of life, morbidity, and mortality. The primary goal …

    • 0 views
    • 19 Sep, 2021
    • 1 location
    Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera ) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects

    This study will be conducted to demonstrate the efficacy and safety of vadadustat administered three times weekly (TIW) compared to a long-acting erythropoiesis-stimulating agent (ESA) (Mircera) for the maintenance treatment of anemia in hemodialysis participants.

    • 6 views
    • 19 Sep, 2021
    • 94 locations
    Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Participants

    This is a two-part, open-label, randomized, crossover study in healthy subjects (vasectomized males and women of non-childbearing potential), performed at 2 study centers.

    • 0 views
    • 12 Sep, 2021
    • 2 locations
    Clinical Evaluation of Vertical Inter-implant Papilla Height in Platform Matched Implants in Comparison to Morse Connection Abutments

    The complete fill of the inter-implant mucosa is much more challenging between two implants, than single implants, and is considered to be unpredictable (Tymstra et al., 2011). However, previous clinical studies have pointed to a relationship between the inter-implant mucosa fill and the horizontal distance between two adjacent implants. In …

    • 0 views
    • 19 Sep, 2021
    • 1 location